The Government has allocated £5 million in seed funding to the Fleming Centre, a new initiative led by Imperial College London, to combat antimicrobial resistance (AMR). This funding forms part of a broader investment to strengthen the UK's life sciences sector. Set to open in 2028 in the hospital where Sir Alexander Fleming discovered the first antibiotic, the Fleming Centre aims to address the global challenge of AMR, which causes over one million deaths annually. AMR occurs when microorganisms develop resistance to treatments like antibiotics, posing a significant public health threat. The centre is committed to placing society at the forefront of solving AMR. Jeremy Hunt emphasised its role in inspiring future world-changing innovations, and Professor Lord Darzi highlighted the importance of this funding in developing the centre and addressing this urgent challenge. See